Theoretical study of the sequence specificity in the covalent binding of the antitumor drug CC-1065 to DNA.
AUTOR(ES)
Zakrzewska, K
RESUMO
A theoretical modelling is presented of the covalent adducts of the antitumor agent CC-1065 with B-DNA. The optimal complexes are obtained by energy minimisation, taking into account full structure flexibility, including the flexible rings of the ligand and DNA. The binding preference of CC-1065 with respect to base sequence is studied. The results obtained elucidate the origin of the preference for two AT base pairs on the 5'side of the modified adenine. The modifications of the DNA structure upon ligand covalent binding are discussed.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=306022Documentos Relacionados
- Synthesis and cytotoxicity of a biotinylated CC-1065 analogue
- CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agents.
- Characterization of an adduct between CC-1065 and a defined oligodeoxynucleotide duplex.
- Demonstration of the asymmetric effect of CC-1065 on local DNA structure using a site-directed adduct in a 117-base-pair fragment from M13mp1.
- Sequence-specific binding of luzopeptin to DNA.
